Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020

Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025

Published:2021-09-11 Issue:1 Volume:63 Page:54-63
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kanas Gena¹^ORCID,Ge Wenzhen²^ORCID,Quek Ruben G. W.²^ORCID,Keeven Katie¹,Nersesyan Knar¹,Jon E. Arnason ³

Affiliation:

1. Kantar Health, New York, NY, USA

2. Regeneron Pharmaceuticals Inc. – Health Economics & Outcomes Research, Tarrytown, NY, USA

3. Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA

Funder

Regeneron Pharmaceuticals, Inc

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1975188

Reference40 articles.

1. GLOBOCAN. Cancer today [Internet]. [cited 2021 Jan 19]. Available from: http://gco.iarc.fr/today/home

2. SEER Cancer Stat Facts [Internet]. SEER. [cited 2021 Feb 1]. Available from: https://seer.cancer.gov/statfacts/index.html

3. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for B-Cell Lymphomas V.4.2020. ©National Comprehensive Cancer Network, Inc. 2021. All rights reserved. [cited 19 Jan 2021]. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

4. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Direct Costs Associated with Relapsed Diffuse Large B-Cell Lymphoma Therapies

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glofitamab as a salvage treatment for B‐cell lymphomas in the real world: A multicenter study in Taiwan;Cancer;2024-02-02

2. Diffuse large B-cell lymphoma: strokes to the epidemiological portrait. A review;Journal of Modern Oncology;2023-12-10

3. Filling the Gaps in Oncofertility Care by Addressing Challenges Faced by Patients and Providers;Cureus;2023-12-09

4. Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma;Annals of Internal Medicine;2023-12

5. Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone;Clinical Lymphoma Myeloma and Leukemia;2023-11